Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Transcranial photobiomodulation as an adjunctive therapy for persistent anxiety and depression in patients undergoing psychotherapy, EMDR, and/or SSRI treatment: A case series

TPBM may serve as an effective adjunctive therapy for anxiety and depression in patients undergoing conventional interventions with minimal improvement.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report a case series of three adult women with chronic anxiety and depression who received a 12-week transcranial photobiomodulation protocol alongside ongoing therapy. All three showed reduced DASS-21 depression scores, while anxiety outcomes varied. The authors describe the findings as preliminary and note that larger samples and control groups are needed.

Participants
3
Who or what was studied
Three adult female participants with chronic anxiety and depression receiving CBT, EMDR, and/or SSRIs
Wavelengths
1070 nm
Limits stated in the abstract
The study has only three participants and no control group, and the authors state that larger samples and control groups are needed to validate the preliminary findings.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Recurrent depression and anxiety can be resistant to monotherapies, including psychotherapy, eye movement desensitization and reprocessing (EMDR), and selective serotonin reuptake inhibitors (SSRIs). Transcranial photobiomodulation (TPBM), a non-invasive neuromodulation therapy that uses near-infrared light, has shown antidepressant effects in animal studies and randomized clinical trials.

Objective

To evaluate the potential therapeutic effect of TPBM as an adjunctive intervention for patients experiencing persistent anxiety and depression despite receiving psychotherapy, EMDR, and taking SSRIs.

Methods

Three adult female participants experiencing chronic anxiety and depression completed a 12-week TPBM protocol using a Neuronic 1070 nm helmet (10 Hz, 75-100 % intensity, 10-15 min daily). All participants were concurrently undergoing CBT and EMDR; two were taking SSRIs. Outcome measures included the GAD-7, DASS-21, and Cognifit cognitive testing at baseline, week 6, and week 12. Participant feedback was collected at all intervals.

Results

All three participants completed the protocol with over 92 % adherence. Two participants reported improved sleep quality and reduced irritability. All three participants showed reductions in DASS-21 depression scores, although GAD7 anxiety and DASS21 anxiety and stress outcomes varied. One participant reported no perceived benefit despite objective improvement, highlighting the potential influence of cognitive attribution patterns.

Conclusion

TPBM may serve as an effective adjunctive therapy for anxiety and depression in patients undergoing conventional interventions with minimal improvement. Further studies with larger samples and control groups are needed to validate these preliminary findings.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
1070 nm

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Anxiety, Transcranial photobiomodulation, Depression, Photobiomodulation, Neuromodulation, Near-infrared, Neuronic. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies